Welcome to our dedicated page for Central Garden & Pet Co SEC filings (Ticker: CENTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Central Garden & Pet Company (NASDAQ: CENTA) files reports with the U.S. Securities and Exchange Commission that provide detailed information about its operations in the pet and garden industries. As a NASDAQ-listed issuer, Central uses SEC filings to disclose financial performance, segment results, capital structure, and material events affecting the company.
On this page, you can review Central’s key filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe the performance of its Pet and Garden segments, discuss factors influencing net sales and margins, and outline initiatives such as its Cost and Simplicity agenda and Supply Network Design project. These reports also present information on liquidity, debt, and other balance sheet items.
Current reports on Form 8-K provide timely updates on specific events. Recent 8-K filings have covered topics such as quarterly financial results and changes to the company’s outlook. These documents help investors understand how Central responds to evolving conditions in the pet and garden markets and how management communicates significant developments.
In addition to periodic and current reports, this page can surface other relevant filings, such as proxy materials and, where applicable, insider transaction reports on Form 4 that show purchases or sales of Central securities by officers, directors, or significant shareholders. Stock Titan enhances access to these documents with AI-powered summaries that explain the main points of lengthy filings, highlight segment trends, and clarify technical disclosures, helping readers navigate CENTA’s regulatory information more efficiently.
Central Garden & Pet Company director and chairman William E. Brown reported a bona fide gift of 2,040 shares of Class A Common Stock. The gift was recorded at a price of $0.00 per share and is classified as a disposition for reporting purposes.
After the gift, Brown holds 937,548 Class A shares directly. An additional 374,258 Class A shares are held indirectly by various family Irrevocable Trusts, where Brown and his spouse serve as co‑trustees with shared investment control and disclaim beneficial ownership except to the extent of their pecuniary interest.
Central Garden & Pet Co: The Vanguard Group filed Amendment No. 19 to its Schedule 13G/A regarding Common Stock, reporting 0 shares beneficially owned and 0% of the class. The filing notes an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries to report separately.
Central Garden & Pet Co Amendment No. 14 to a Schedule 13G/A states that The Vanguard Group reports 0 shares of Common Stock beneficially owned, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that led certain Vanguard subsidiaries to report holdings separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026, and lists the issuer's principal executive office at 1340 Treat Blvd, Suite 600, Walnut Creek, CA.
Schwichtenberg Kay reported acquisition or exercise transactions in this Form 4 filing.
CENTRAL GARDEN & PET CO director Kay Schwichtenberg received 3,734 shares of Class A Common Stock as a restricted stock award. The shares were granted at no cash cost under the company’s Nonemployee Director Equity Incentive Plan. Following this grant, she directly holds 3,734 Class A shares.
The filing also reports 303 Class A shares held indirectly by the Kay Schwichtenberg Living Trust. She disclaims beneficial ownership of the trust’s common and Class A shares except to the extent of her pecuniary interest in that trust.
Central Garden & Pet Co director Kay Schwichtenberg reports indirect ownership of 303 shares of Class A Common Stock. The shares are held by the Kay Schwichtenberg Living Trust, and she disclaims beneficial ownership except to the extent of her pecuniary interest in the trust.
Central Garden & Pet (CENT) director‑related trust reports share sale. A trust associated with director John Ranelli, the John R. Ranelli Trust, sold 3,668 shares of Class A Common Stock in an open‑market transaction on February 19, 2026 at an average price of $34.4968 per share.
The footnotes state the sale prices ranged from $34.455 to $34.56. After this sale, the trust held 646 Class A shares, while Ranelli also had 3,584 Class A shares held directly and 7,039 shares of Common Stock held indirectly through the trust. He disclaims beneficial ownership of the trust’s shares except to the extent of his pecuniary interest.
CENT filed a Form 144 reporting proposed transfers of Class A Common Stock by an affiliate. The filing lists transfers of 781 shares on 08/13/2024 and 2,887 shares on 02/10/2026, each described as transferred from John R. Ranelli who acquired the shares from compensation. Timing of any market sales is not stated.
Central Garden & Pet Company appointed longtime executive Kay M. Schwichtenberg to its Board of Directors and Audit Committee, effective March 1, 2026. She brings more than 40 years of animal health experience, including 29 years with the company.
The Compensation Committee set fiscal 2025 cash bonuses and updated total compensation for named executive officers, with CEO Nicholas Lahanas receiving $1,134,000 in non-equity incentive pay and total 2025 compensation of $3,039,762. Base salaries for key executives, including an increase in Mr. Lahanas’s salary to $990,000, became effective January 1, 2026, alongside new restricted stock and stock option grants under the 2003 Omnibus Equity Incentive Plan.
Shareholders elected all director nominees, ratified Deloitte & Touche LLP as auditor, and approved on an advisory basis the executive compensation package. The Board also increased the stock repurchase authorization by $100 million, bringing total authorized repurchases to approximately $127 million with no expiration date.
PENNINGTON BROOKS III reported disposition transactions in a Form 4 filing for CENT. The filing lists transactions totaling 2,050 shares. Following the reported transactions, holdings were 128,906 shares.
Central Garden & Pet Company has an investor planning to sell 5,000 shares of Class A common stock under Rule 144. The proposed sale has an aggregate market value of $173,760 and is expected around February 17, 2026 on the NASDAQ through Charles Schwab.
The 5,000 shares were acquired on August 6, 2024 through a restricted stock lapse as part of equity compensation. Central Garden & Pet Company had 51,014,844 shares of this class outstanding, providing context for the size of the planned sale.